TSTS

That Marketing Solution, Inc. TSTS

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode TSTS SCRCQ LGND NVNO IRBS ACUS TOMDF NEPTF EMYSF XTXXF
6M 0.00 % 0.00 % 75.62 % -92.10 % 0.00 % 0.00 % 0.00 % -98.00 % 0.00 % -47.09 %
YTD 0.00 % 0.00 % 84.77 % -89.58 % 0.00 % 0.00 % 0.00 % 9 900.00 % 0.00 % 57.48 %
1Y 0.00 % 0.00 % 76.04 % -89.00 % 0.00 % 0.00 % 900.00 % -99.50 % 0.00 % 57.48 %
3Y 900.00 % 0.00 % 206.93 % -93.59 % 5 900.00 % 0.00 % -99.90 % -100.00 % 0.00 % -99.20 %
5Y -98.00 % -93.33 % 101.46 % -95.89 % 5 900.00 % -99.97 % -99.99 % -100.00 % -81.93 % -99.73 %
10Y -99.47 % -99.81 % 85.70 % -99.76 % 5 900.00 % -99.98 % -100.00 % -100.00 % -98.75 % -99.73 %
From the beginning -100.00 % -99.96 % 336.91 % -99.76 % 5 900.00 % -100.00 % -100.00 % -100.00 % -100.00 % -99.73 %

Dividend

Ligand Pharmaceuticals Incorporated